One in six American men will develop prostate cancer. It is the most common cancer after skin cancer, and the second biggest cancer killer for men. Two Israeli scientists at the Weizmann Institute in Israel promise an almost miraculous cure, now in clinical trials at New York’s Sloan Kettering Cancer Center. It is the culmination of 20 years of basic research by plant scientist Avigdor Scherz and cancer researcher Yoram Saloman. Professor Scherz took a naturally occurring form of chlorophyll from aquatic bacteria: … chemically modified by Prof. Scherz's lab at Weizmann to fit the team's pharmaceutical needs. Once...